Annual EBITDA
-$13.99M$9.74M+41.04%
Summary
- Current Value
- As of today, XERS annual EBITDA is -$13.99M, up +41.04% on
- Historical Performance
- XERS annual EBITDA is up +87.69% over the past 3 years, and up +88.12% over the past 5 years
- All-Time High Comparison
- XERS annual EBITDA is currently -6.90% below its historical high of -$13.09M set on
- 3-Year Low Comparison
- XERS annual EBITDA is +79.81% above its 3-year low of -$69.31M reached on an earlier date
- Sector Comparison
- XERS annual EBITDA is higher than 53.81% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$13.99M | +41.0% | +87.7% | +88.1% | -6.9% | |
| Quarterly EBITDA | $9.92M | +201.6% | +163.5% | +179.0% | +315.1% | |
| TTM EBITDA | $22.43M | +169.2% | +123.8% | +123.7% | +586.5% | |
| Price | $7.21 | +115.2% | +586.7% | +24.3% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $203.07M | +23.9% | +309.5% | +7360.3% | +10000.0% | |
| Annual EPS | -$0.37 | +17.4% | +75.9% | +92.2% | +41.8% | |
| Annual EBIT | -$26.62M | +27.9% | +77.0% | +77.6% | -101.5% | |
| Annual Net Income | -$54.84M | +11.9% | +55.3% | +56.3% | -315.1% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$13.99M | at high | |
| 5Y | -$13.99M | at high | |
| All | -$13.09M | -6.9% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$69.31M | N/A | +79.8% |
| 5Y | -$113.67M | +87.7% | |
| All | -$117.80M | +88.1% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$13.99M | +41.0% | |
| -$23.74M | +65.8% | |
| -$69.31M | +39.0% | |
| -$113.67M | -43.7% | |
| -$79.12M | +32.8% |
| Year | Value | Change |
|---|---|---|
| -$117.80M | -105.9% | |
| -$57.22M | -117.3% | |
| -$26.33M | -101.1% | |
| -$13.09M | - |
FAQ
What is the current annual EBITDA of XERS?
As of today, XERS annual EBITDA is -$13.99M
What is 1-year change in XERS annual EBITDA?
XERS annual EBITDA is up +41.04% year-over-year
What is 3-year change in XERS annual EBITDA?
XERS annual EBITDA is up +87.69% over the past 3 years
How far is XERS annual EBITDA from its all-time high?
XERS annual EBITDA is currently -6.90% below its historical high of -$13.09M set on December 31, 2016
How does XERS annual EBITDA rank versus sector peers?
XERS annual EBITDA is higher than 53.81% of companies in Healthcare sector
When is XERS next annual earnings release?
The next annual earnings release for XERS is on
Quarterly EBITDA
$9.92M$2.27M+29.74%
Summary
- Current Value
- As of today, XERS quarterly EBITDA is $9.92M, up +29.74% on
- Historical Performance
- XERS quarterly EBITDA is up +201.55% year-over-year, and up +163.46% over the past 3 years
- All-Time High Comparison
- XERS quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- XERS quarterly EBITDA is +178.63% above its 3-year low of -$12.62M reached on
- Sector Comparison
- XERS quarterly EBITDA is higher than 78.07% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $9.92M | +29.7% | +201.6% | +163.5% | +179.0% | |
| Annual EBITDA | -$13.99M | – | +41.0% | +87.7% | +88.1% | |
| TTM EBITDA | $22.43M | +718.0% | +169.2% | +123.8% | +123.7% | |
| Price | $7.21 | -12.9% | +115.2% | +586.7% | +24.3% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $74.38M | +4.0% | +37.1% | +150.2% | +687.3% | |
| Quarterly EPS | $0.00 | +128.9% | +103.3% | +102.2% | +101.0% | |
| Quarterly EBIT | $6.73M | +50.2% | +152.2% | +136.0% | +152.0% | |
| Quarterly Net Income | $621.00K | +132.2% | +104.0% | +102.8% | +103.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $9.92M | at high | |
| 3Y | $9.92M | at high | |
| 5Y | $9.92M | at high | |
| All | $9.92M | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $53.00K | >+9999.0% | |
| 3Y | -$12.62M | +178.6% | |
| 5Y | -$37.97M | +126.1% | |
| All | -$37.97M | +126.1% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of XERS?
As of today, XERS quarterly EBITDA is $9.92M
What is XERS quarterly EBITDA most recent change?
XERS quarterly EBITDA was up +29.74% on September 30, 2025
What is 1-year change in XERS quarterly EBITDA?
XERS quarterly EBITDA is up +201.55% year-over-year
How far is XERS quarterly EBITDA from its all-time high?
XERS quarterly EBITDA is currently at its all-time high
How does XERS quarterly EBITDA rank versus sector peers?
XERS quarterly EBITDA is higher than 78.07% of companies in Healthcare sector
When is XERS next earnings release?
The next earnings release for XERS is on
TTM EBITDA
$22.43M$19.69M+718.05%
Summary
- Current Value
- As of today, XERS TTM EBITDA is $22.43M, up +718.05% on
- Historical Performance
- XERS TTM EBITDA is up +169.20% year-over-year, and up +123.84% over the past 3 years
- All-Time High Comparison
- XERS TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- XERS TTM EBITDA is +133.09% above its 3-year low of -$67.78M reached on an earlier date
- Sector Comparison
- XERS TTM EBITDA is higher than 78.16% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $22.43M | +718.0% | +169.2% | +123.8% | +123.7% | |
| Annual EBITDA | -$13.99M | – | +41.0% | +87.7% | +88.1% | |
| Quarterly EBITDA | $9.92M | +29.7% | +201.6% | +163.5% | +179.0% | |
| Price | $7.21 | -12.9% | +115.2% | +586.7% | +24.3% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $266.14M | +8.2% | +42.0% | +170.1% | +1659.3% | |
| TTM EPS | -$0.10 | +51.3% | +76.4% | +89.9% | +96.7% | |
| TTM EBIT | $9.80M | +199.8% | +121.7% | +109.4% | +110.2% | |
| TTM Net Income | -$15.64M | +51.1% | +75.2% | +88.2% | +84.7% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $22.43M | at high | |
| 3Y | $22.43M | at high | |
| 5Y | $22.43M | at high | |
| All | $22.43M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$21.02M | N/A | +206.7% |
| 3Y | -$67.78M | N/A | +133.1% |
| 5Y | -$111.90M | +120.0% | |
| All | -$123.93M | +118.1% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of XERS?
As of today, XERS TTM EBITDA is $22.43M
What is XERS TTM EBITDA most recent change?
XERS TTM EBITDA was up +718.05% on September 30, 2025
What is 1-year change in XERS TTM EBITDA?
XERS TTM EBITDA is up +169.20% year-over-year
How far is XERS TTM EBITDA from its all-time high?
XERS TTM EBITDA is currently at its all-time high
How does XERS TTM EBITDA rank versus sector peers?
XERS TTM EBITDA is higher than 78.16% of companies in Healthcare sector
When is XERS next earnings release?
The next earnings release for XERS is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- XERS Official Website www.xerispharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1867096/000186709625000159/0001867096-25-000159-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1867096/000186709625000039/0001867096-25-000039-index.htm
- XERS Profile on Yahoo Finance finance.yahoo.com/quote/XERS
- XERS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/xers